MedTrace Logo

Trigger Time in Advanced Maternal Age Patients With Low AMH

NCT03740880 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2022-03-04

No results posted yet for this study

Summary

The investigators want to verify if advanced maternal age patients with a low Anti-Müllerian hormone (AMH) level may benefit from an early trigger time (compared to a late trigger).

Conditions

  • the Number of Mature Oocytes

Interventions

OTHER

Dual trigger

dual trigger: 10.000 IU hCG i.m. and 0.3 mg Deca

Sponsors & Collaborators

  • ART Fertility Clinics LLC

    lead OTHER

Principal Investigators

  • Neelke De Munck, PhD · IVIRMA Abu Dhabi

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
48 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-07
Primary Completion
2020-03-12
Completion
2020-03-30

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03740880 on ClinicalTrials.gov